0001824293-23-000104.txt : 20230424 0001824293-23-000104.hdr.sgml : 20230424 20230424183014 ACCESSION NUMBER: 0001824293-23-000104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230421 FILED AS OF DATE: 20230424 DATE AS OF CHANGE: 20230424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hertz Walter Marc CENTRAL INDEX KEY: 0001971132 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40034 FILM NUMBER: 23841238 MAIL ADDRESS: STREET 1: 2223 AVIENDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GRI BIO, Inc. CENTRAL INDEX KEY: 0001824293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824369909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (619) 400-1171 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Vallon Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20200910 4 1 wf-form4_168237539956604.xml FORM 4 X0407 4 2023-04-21 0 0001824293 GRI BIO, Inc. GRI 0001971132 Hertz Walter Marc C/O GRI BIO, INC. 2223 AVENIDA DE LA PLAYA, SUITE 208 LA JOLLA CA 92037 1 1 1 0 Chief Executive Officer 0 Common Stock 2023-04-21 4 A 0 385510 A 385510 D Received in exchange for 10,307,793 shares of common stock of GRI Bio, Inc. ("GRI"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the "Company"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the "Merger"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the "Reverse Split"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split. /s/ Leanne Kelly, Attorney-in-Fact 2023-04-24